AmberGen
Billerica
About AmberGen
At AmberGen, we create and market technologies and services that enable drug developers, disease researchers, and physicians to obtain several orders of magnitude greater spatially-resolved information across a wide spectrum of different classes of biomarkers from precious bio-samples, such as biopsies which was previously not possible.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.3M
- Funding stage: Late Stage Venture
- Last round: Grant (May 2023)
- Website: ambergen.com
- Phone: (978) 362-1131
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/ambergen-69493 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.